Abingdon Health acquires IVDeology in £0.7m deal
7th May 2024 13:20
(Sharecast News) - Lateral flow contract research, development and manufacturing provider Abingdon Health announced the acquisition of IVDeology and its subsidiaries on Tuesday, for up to £0.7m.
Read moreAbingdon Health progresses at-home STD test programme
25th Mar 2024 15:27
(Sharecast News) - Abingdon Health updated the market on the development of self-tests for sexually transmitted diseases (STDs) on Monday, announcing the completion of the 'design freeze' stage for four key tests in collaboration with Devyn.
Read moreAbingdon Health to launch two Boots-branded self-tests
20th Mar 2024 11:00
(Sharecast News) - Lateral flow test specialist Abingdon Health announced a partnership with Crest Medical on Wednesday, to introduce Boots' own-brand rapid self-tests across the UK and online.
Read moreAbingdon Health upbeat on strong recent progress
15th Dec 2023 11:18
(Sharecast News) - Lateral flow contract research, development and manufacturing organisation Abingdon Health reported solid progress on Friday as it held its annual general meeting.
Read moreAbingdon rolling out saliva-based pregnancy test to Tesco stores
15th Aug 2023 12:41
(Sharecast News) - Abingdon Health announced on Tuesday that grocery giant Tesco was launching 'Salistick' - its saliva-based pregnancy test - in 298 of its shops and on its online platform from late August.
Read moreAbingdon Health rolling out saliva-based pregnancy test
19th Jun 2023 11:20
(Sharecast News) - Abingdon Health announced the release of 'Salistick', a saliva pregnancy test, in the United Kingdom and Ireland on Monday.
Read moreAbingdon Health strikes strategic partnership with Senzo
20th Mar 2023 10:01
(Sharecast News) - Diagnostic tests manufacturer Abingdon Health has entered into a strategic partnership with lateral flow technology group Senzo.
Read moreAbingdon Health confident moving into 2023
19th Dec 2022 13:51
(Sharecast News) - Diagnostic test developer and manufacturer Abingdon Health said in an update on Monday that its outlook moving into 2023 remained unchanged.
Read moreAbingdon expects 'substantial' loss after disappointing year
15th Aug 2022 10:53
(Sharecast News) - Rapid medical test developer Abingdon Health described a "disappointing" full-year performance in a trading update on Monday, with revenues expected to be in the region of £2.8m, and a "substantial loss" anticipated.
Read moreAbingdon Health reaches £6.3m settlement with DHSC
28th Jun 2022 11:19
(Sharecast News) - Rapid testing kits manufacturer Abingdon Health has reached a settlement agreement with the Department for Health and Social Care on outstanding invoices payable to the group for lateral flow tests and component stock.
Read moreAbingdon Health wins 'significant' rapid Covid test contract
17th May 2022 12:51
(Sharecast News) - Rapid test developer and manufacturer Abingdon Health announced a "significant contract" with a European customer on Friday, for the production of lateral flow device (LFD) components for a Covid-19 antigen test.
Read moreAbingdon Health surges after launch of Covid-19 antibody self-test
23rd Aug 2021 07:43
(Sharecast News) - Abingdon Health surged on Monday after launching a Covid-19 antibody self-test it manufactured with BioSure.
Read moreAbingdon Health FY revenues at bottom end of guidance
12th Aug 2021 09:15
(Sharecast News) - Covid-19 test kit manufacturer Abingdon Health warned on Thursday that full-year revenues would be at the bottom end of forecasts.
Read moreAbingdon Health looks set to report FY underlying loss
27th Apr 2021 09:54
(Sharecast News) - Abingdon Health warned on Tuesday that it looked set to post a full-year underlying loss despite stating it had continued to make progress on commercialising its AbC-19TM rapid test in the UK private sector and internationally.
Read moreAbingdon Health inks sales and distribution agreement with BioSure UK
10th Mar 2021 09:27
(Sharecast News) - Rapid tests developer Abingdon Health has signed a non-exclusive sales and distribution agreement in the UK and Europe for its AbC-19 rapid neutralising antibody test with BioSure UK.
Read more